Switching Inhaler Type for Certain Patients Can Substantially Reduce CO2 Emissions

While inhalers are essential treatments for managing COPD and asthma, they contribute to CO2-equivalent emissions (CO2eq). However, switching from metered-dose inhalers (MDIs), which use hydrofluoroalkane (HFA) propellants, to dry powder inhalers (DPIs) in certain patient groups can substantially reduce healthcare-related CO2eq, according to a study published in BMJ Open Respiratory Research.

Advertisement
Advertisement
Advertisement

DocWire Content Partners

Powered by DocWire News

The Latest From GI Oncology Now

The Latest From Heme Today

Expert Interviews

Network Websites